The investigational triple agonist posted the largest trial weight loss ever reported, roughly 28 percent at 80 weeks, and the internet is full of misinformation about it
Regulating a Miracle Drug: GLP-1 Costs, Access, & Safety Understanding GLP-1 Drugs: Cost, Safety, and Access in Context New Weight Loss Drugs (GLP-1s) Explained: Science, Impact, Potential Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for Central Nervous System Disorders Disclaimer: The information provided on this website is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment
Retatrutide is an unlicensed investigational tri-agonist (GLP-1, GIP, glucagon) with no MHRA or EMA marketing authorisation as of 2024
Suggested Use: Take 1 to 2 capsules daily with water, preferably with a meal
Medications for diabetes: Medications used to treat type 1 or type 2 diabetes, including insulin or sulfonylureas (such as Amaryl or Glucotrol XL)